We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current PMVP market cap is 102.37M. The company's latest EPS is USD -1.3405 and P/E is -1.48.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.38M | -21.16M | -21.48M | -20.12M | -19.63M |
| Net Income | -18.23M | -19.35M | -19.13M | -17.44M | -16.64M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -26.64M | -34.94M | -58.29M | -77.04M | -80.13M |
| Net Income | -25.35M | -34.44M | -57.85M | -73.32M | -68.96M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 284.98M | 270.31M | 253.96M | 242.22M | 261.03M |
| Total Liabilities | 23.79M | 24.28M | 23.79M | 24.41M | 23.42M |
| Total Equity | 261.19M | 246.03M | 230.17M | 217.81M | 237.61M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 103.03M | 365.53M | 331.57M | 270.31M | 252.15M |
| Total Liabilities | 4.57M | 6.41M | 23.01M | 24.28M | 26.46M |
| Total Equity | -70.47M | 359.12M | 308.56M | 246.03M | 225.69M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -48.44M | -63.76M | -15.01M | -27.91M | -43.57M |
| Investing | -24.59M | -1.37M | 49.65M | -14.32M | -47.96M |
| Financing | 410k | 958k | 12k | 2.14M | 35.29M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.07M | -32.74M | -46.57M | -63.76M | -55.66M |
| Investing | 3.23M | 27.91M | -143.58M | -1.37M | -50.55M |
| Financing | 61.81M | 292.97M | 2.02M | 958k | 35.58M |
| Market Cap | 102.37M |
| Price to Earnings Ratio | -1.48 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.71 |
| Price to Book Ratio | 0.45 |
| Dividend Yield | - |
| Shares Outstanding | 51.44M |
| Average Volume (1 week) | 494.48k |
| Average Volume (1 Month) | 482.35k |
| 52 Week Change | -59.30% |
| 52 Week High | 9.72 |
| 52 Week Low | 1.175 |
| Spread (Intraday) | 0.87 (34.66%) |
| Company Name | PMV Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.pmvpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
